DCF — HOUSTON NORTHWEST MEDICAL CENTER
Enterprise Value: $108.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$108.8M
Enterprise Value
$23.2M
PV of Cash Flows
$85.6M
PV of Terminal Value
$137.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $353.5M | $19.2M | 5.0% | $1.7M | $1.5M |
| Year 2 | $364.1M | $23.5M | 6.0% | $4.5M | $3.7M |
| Year 3 | $375.0M | $27.9M | 7.0% | $7.4M | $5.6M |
| Year 4 | $386.3M | $30.7M | 8.0% | $9.1M | $6.2M |
| Year 5 | $397.9M | $32.6M | 8.0% | $10.1M | $6.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $108.8M. Terminal value accounts for 79% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$343.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.04940811694742359
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5